Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PorA outer membrane protein is a porin and major outer membrane component found in certain Gram-negative bacteria, especially *Neisseria meningitidis* and *Corynebacterium glutamicum*. PorA forms β-barrel channels that allow the passive diffusion of small hydrophilic molecules across the bacterial outer membrane[4][5][7]. In *Neisseria meningitidis*, PorA is a highly immunogenic and variable antigen targeted by bactericidal antibodies, making it a critical determinant in vaccine design and epidemiological typing. The porin structure typically assembles as homotrimers, each subunit contributing to a water-filled channel[5]. In the context of pathogenesis, PorA is a key factor in immune evasion, membrane integrity, and antibiotic influx, with its expression and variability influencing disease susceptibility and vaccine efficacy[5][7]. PorA is not a therapeutic target for drugs in the conventional sense (like receptors or enzymes), but is a validated antigenic component for subunit or conjugate vaccines against *Neisseria*. PorA is a defining member of the family "Porin Superfamily V (Corynebacterial PorA/PorH Superfamily)"[5]. In *Neisseria*, PorA is used for molecular epidemiology and is a key vaccine determinant in multicomponent meningococcal vaccines[5]. PorA's function is structural (membrane channel) and immunological (major antigen), but it does not function as a receptor or enzyme[5][7]. There are no direct small molecule ligands (drugs) for PorA; its targeting is primarily immunological (antibodies in vaccines)[5].
For vaccines, PorA serves as an antigen, stimulating an immune response that leads to bacterial killing via antibody-mediated complement activation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PorA outer membrane protein (PorA).